Radiopharm Theranostics (RDPTF) Pension (2024 - 2025)
Radiopharm Theranostics' (RDPTF) quarterly Pension came in at $450104.0 in Q2 2025, up 12.59% year-over-year from $399788.0 in Q2 2024, and up 9.73% quarter-over-quarter from $410201.0 in Q4 2024.
Powered by 
Analysis
Radiopharm Theranostics (RDPTF) Pension (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RDPTF) has reported Pension for 2 consecutive years, with $450104.0 the latest figure, recorded in Q2 2025.
- On a quarterly basis, Pension rose 12.59% year-over-year to $450104.0 in Q2 2025; TTM through Jun 2025 was $450104.0, a 12.59% increase from a year earlier, with the FY2025 full-year figure at $450104.0, up 12.59% from the prior year.
- Pension was $450104.0 for Q2 2025 at Radiopharm Theranostics, up from $410201.0 in the prior quarter.
- Over five years, Pension peaked at $450104.0 in Q2 2025 and troughed at $399788.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn |
| 10 | Radiopharm Theranostics | 23.65 Mn | 23.60 Mn | -92,644.38 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 450,104.00 |
| Dec 31, 2024 | 410,201.00 |
| Jun 30, 2024 | 399,788.00 |